Program By Day

 

6:30 AM-7:55 AM Complimentary Continental Breakfast
7:00 AM-7:00 PM Exhibits Open
7:00 AM-7:45 AM Best of Journals: Prostate

Matthew R. Cooperberg, MD, MPH
University of California, San Francisco
Surgery

Alberto Bossi, MD
Institut Gustave Roussy
Radiation Oncology

Johann S. De Bono, MD, PhD, FRCP
The Institute of Cancer Research and The Royal Marsden Hospital
Medical Oncology

Panel Question and Answer
7:55 AM-9:30 AM Welcome and General Session 4: Current and Future Directions of Muscle-Invasive Bladder Cancer

Jeanny B. Aragon-Ching, MD, FACP—Chair
Inova Schar Cancer Institute

Nicholas J. Van As, FRCR—Chair
The Royal Marsden NHS Foundation Trust

Jeffrey M. Holzbeierlein, MD, FACS
 University of Kansas Health System
Welcome and Lessons Learned From New Guidelines and How They Have Changed Management of Muscle-Invasive Bladder Cancer

Peter C. Black, MD
University of British Columbia
Selective Versus Nonselective Use of Neoadjuvant Chemotherapy: Use of Molecular Markers for Identifying Patients and Therapies

Peter Hoskin, MD, FRCP, FRCR
Mount Vernon Cancer Centre
Use of Molecular Markers in Bladder Preservation Therapy

Abhishek A. Solanki, MD
University of Chicago Medical Center
Role of Immunotherapy in Patients Undergoing Radiation Therapy for Bladder Cancer

Panel Question and Answer
9:30 AM-10:15 AM Urothelial Carcinoma: Keynote Lectures

Thomas Powles, MD
Barts Cancer Institute
Immune Checkpoint Inhibitors: Which One and Why?

Seth P. Lerner, MD
Baylor College of Medicine
Update on The Cancer Genome Atlas

Panel Question and Answer
10:15 AM-10:45 AM Break
10:45 AM-12:15 PM General Session 5: Multimodality Approach to Locally Advanced Bladder Cancer (ARS)

Ananya Choudhury, MA, PhD, MRCP, FRCR—Chair
The Christie NHS Foundation Trust and University of Manchester

Yair Lotan, MD—Chair
The University of Texas Southwestern Medical Center

Case Panel Discussion

Alison J. Birtle, MRCP, FRCR, MD
Lancashire Teaching Hospitals NHS Trust
Radiation Oncologist

TBD
Urologist

Dean F. Bajorin, MD, FACP, FASCO
Memorial Sloan-Kettering Cancer Center
Medical Oncologist

Panel Question and Answer
12:15 PM-1:45 PM Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
With Complimentary Boxed Lunch
12:15 PM-1:45 PM Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers
With Complimentary Boxed Lunch
12:45 PM-1:30 PM Poster Walks
1:15 PM-3:15 PM Oral Abstract Session B: Urothelial Carcinoma and Penile, Urethral, and Testicular Cancers
3:15 PM-3:45 PM Break
3:45 PM-5:15 PM General Session 6: Management of Post-Chemotherapy Residual Masses

Silke Gillessen, MD—Chair
Kantonsspital St. Gallen

Padraig R. Warde, MB MRCPI, FRCPC—Chair
Princess Margaret Cancer Centre

TBD
The Role of Imaging in Post-chemotherapy Masses in Germ Cell Tumors

Case-Based Panel: Management of Residual Masses in Germ Cell Tumors

Christopher G. Wood, MD
The University of Texas MD Anderson Cancer Center
Surgeon

Donna E. Hansel, MD, PhD
University of California, San Diego
Pathologist

Costantine Albany, MD
Indiana University Melvin and Bren Simon Cancer Center
Medical Oncologist

Timothy N. Showalter, MD, MPH
University of Virginia
Radiation Oncologist

Panel Question and Answer
5:15 PM-6:00 PM Adrenal and Testicular Cancers: Keynote Lectures

TBD
Adrenal Carcinoma

Christian Kollmannsberger, MD
BCCA Vancouver Cancer Centre
Testicular Cancer

Panel Question and Answer
6:00 PM-7:00 PM Rapid-Fire Abstract Session: Penile, Urethral, and Testicular Cancers
6:00 PM-7:00 PM Rapid-Fire Abstract Session: Urothelial Carcinoma
6:00 PM-7:00 PM Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers, Continued
With Complimentary Wine and Cheese
6:00 PM-7:00 PM Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers, Continued
With Complimentary Wine and Cheese